Casey Marie Cale, OT in Bixby, OK - Occupational Therapist

Casey Marie Cale, OT is a Occupational Therapist - Pediatrics based in Bixby, Oklahoma. Casey Marie Cale is licensed to practice in Oklahoma (license number 1716) and her current practice location is 109 N Armstrong St, Bixby, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (918) 366-2200.

NPI number for Casey Marie Cale is 1538439773 and her current mailing address is 109 N Armstrong St, Bixby, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1538439773.

Contact Information

	Casey Marie Cale, OT
	109 N Armstrong St, Bixby, OK 74008-4449
	(918) 366-2200
	(918) 366-2365

Healthcare Provider's Profile

Full Name	Casey Marie Cale
Gender	Female
Speciality	Occupational Therapist - Pediatrics
Location	109 N Armstrong St, Bixby, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1538439773
Provider Enumeration Date: 01/05/2012
Last Update Date: 01/27/2023

Medical Identifiers

Medical identifiers for Casey Marie Cale such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538439773	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225XP0200X	Occupational Therapist - Pediatrics	1716 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Casey Marie Cale is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Casey Marie Cale, OT 109 N Armstrong St, Bixby, OK 74008-4449 Ph: (918) 366-2200	Casey Marie Cale, OT 109 N Armstrong St, Bixby, OK 74008-4449 Ph: (918) 366-2200

News Archive

APCER PHARMA to demonstrate pharmacovigilance/drug safety and regulatory services at GPhA meeting

APCER PHARMA executives will discuss and demonstrate their expertise in providing generic drug manufacturers with the best in class pharmacovigilance/drug safety, regulatory and risk management services at the GPhA Annual Meeting, February 16-18, at the Ritz-Carlton in Naples, Florida. APCER will be in Booth #27.

Bruker acquires Lactotronic to expand product portfolio for milk and dairy analysis

Bruker announced today that it has acquired the business of Lactotronic B.V., a Dutch developer and manufacturer of analytical instruments for the dairy industry, with 25 years of experience in milk analysis. Financial details were not disclosed.

Pacira Pharmaceuticals reports results of EXPAREL Phase 2/3 clinical trial for TKA

Pacira Pharmaceuticals, Inc. today announced findings from the completed first part of its Phase 2/3 clinical trial assessing the use and administration of EXPAREL (bupivacaine liposome injectable suspension) as a single-dose injection femoral nerve block for total knee arthroplasty surgery.

Intellipharmaceutics files generic 30 mg Focalin XR ANDA with FDA

Intellipharmaceutics International Inc., today announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for approval to market a generic of the 30 mg strength of Focalin XR® (dexmethylphenidate hydrochloride). The application for the 30 mg strength is filed as an amendment to the ANDA that Intellipharmaceutics had previously filed for the 5, 10, 15 and 20 mg strengths of the drug.

MJFF selects Epitomics to distribute LRRK2 monoclonal antibodies

Epitomics, Inc. today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) has chosen the company to distribute a panel of LRRK2 monoclonal antibodies that were developed under an agreement between the two parties. Under a special arrangement the antibodies are being provided at low cost to the entire PD research community to help advance LRRK2 therapeutic development efforts. The antibodies will be available to Parkinson's researchers in academic/nonprofit and industry labs on a worldwide basis.

Occupational Therapist in Bixby, OK

Erin Crowder, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 109 N Armstrong St, Bixby, OK 74008 Phone: 918-366-2200
Darcy L Kickey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 109 N Armstrong St, Bixby, OK 74008 Phone: 918-366-2200 Fax: 918-366-2315
Mr. Michael Larkins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 109 N Armstrong St, Bixby, OK 74008 Phone: 918-366-2200

Casey Marie Cale, OT - Occupational Therapist in Bixby, OK